See all
 |
Articles: Neuro/Psych pharmacology |
Prior Articles
Inhibitory actions of the gamma-aminobutyric acid in pediatric Sturge-Weber syndrome
Annals of Neurology, 09/18/09
The Toll of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia
Trends in Pharmacological Sciences, 09/18/09 Cost Effectiveness of Glatiramer Acetate and Natalizumab in Relapsing-Remitting Multiple Sclerosis
Applied Health Economics and Health Policy, 09/18/09 Primary amoebic meningoencephalitis: two new cases from Pakistan
Tropical Doctor, 09/18/09 Exclusive Author Commentary Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis
Annals of Neurology, 09/17/09 Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients
Drug and Alcohol Dependence, 09/17/09 Flufenamic acid suppresses epileptiform activity in hippocampus by reducing excitatory synaptic transmission and neuronal excitability
Epilepsia, 09/17/09 HTR2A gene variation is involved in antidepressant treatment response
European Neuropsychopharmacology, 09/17/09 A reassessment of risks and benefits of dopamine agonists in Parkinson's disease
The Lancet Neurology, 09/16/09 A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly
Clinical Endocrinology, 09/16/09 Effects of Paroxetine and Sertraline on Low-Density Lipoprotein Cholesterol: An Observational Cohort Study
CNS Drugs, 09/16/09 The Role of Voriconazole in the Treatment of Central Nervous System Blastomycosis
Annals of Pharmacotherapy, 09/16/09 Effect of the Thromboxane Prostaglandin Receptor Antagonist Terutroban on Arterial Thrombogenesis after Repeated Administration in Patients Treated for the Prevention of Ischemic Stroke
Cerebrovascular Diseases, 09/15/09 The use of topical intranasal fluorescein in endoscopic endonasal repair of cerebrospinal fluid rhinorrhea
Surgical Neurology, 09/15/09 Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action
European Neuropsychopharmacology, 09/15/09 30 years of dynorphins — New insights on their functions in neuropsychiatric diseases
Pharmacology & Therapeutics, 09/15/09 The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants
Trends in Pharmacological Sciences, 09/15/09 A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Effects of a Targeted Exposure of Intravenous Repinotan in Patients With Acute Ischemic Stroke. Modified Randomized Exposure Controlled Trial (mRECT)
Stroke, 09/14/09 Antidepressant use and colorectal cancer risk
Pharmacoepidemiology and Drug Safety, 09/14/09 Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting: An Economic Markov Model Evaluation
Drugs & Aging, 09/14/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Current Opinion in Neurology, Stroke, Seizure, Cephalgia, Brain Injury
more...
|
250 Available Pages
|
|